Format

Send to

Choose Destination
JIMD Rep. 2013;9:7-16. doi: 10.1007/8904_2012_174. Epub 2012 Oct 9.

Novel mutations in the glucocerebrosidase gene of brazilian patients with Gaucher disease.

Author information

1
Laboratório de Identificação Genética (LIG), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos 2350, 90035-903, Porto Alegre, Brazil.
2
Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
3
Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Instituto de Ciências Bäsicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
4
Departamento de Bioquímica, Instituto de Ciências Bäsicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
5
Departamento de Genética, Instituto de Biociências, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
6
Laboratório de Identificação Genética (LIG), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos 2350, 90035-903, Porto Alegre, Brazil. mlpereira@hcpa.ufrgs.br.
7
Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. mlpereira@hcpa.ufrgs.br.
8
Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Instituto de Ciências Bäsicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. mlpereira@hcpa.ufrgs.br.
9
Departamento de Bioquímica, Instituto de Ciências Bäsicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. mlpereira@hcpa.ufrgs.br.

Abstract

Gaucher disease (GD) is an autosomal recessive disorder resulting from glucocerebrosidase (GC) deficiency due to mutations in the gene (GBA) coding for this enzyme. We have developed a strategy for analyzing the entire GBA coding region and applied this strategy to 48 unrelated Brazilian patients with GD. We used long-range PCR, genotyping based on the Taqman® assay, nested PCR, and direct DNA sequencing to define changes in the gene. We report here seven novel mutations that are likely to be harmful: S125N (c.491G>A), F213L (c.756T>G), P245T (c.850C>A), W378C (c.1251G>C), D399H (c.1312G>C), 982-983insTGC (c.980_982dupTGC), and IVS10+1G>T (c.1505+1G>T). The last alteration was found as a complex allele together with a L461P mutation. We also identified 24 different mutations previously reported by others. G377S was the third most frequent mutation among the patients included in this study, after N370S and L444P. Therefore, this mutation needs be included in preliminary screens of Brazilian GD patients. The identification of mutant GBA alleles is crucial for increasing knowledge of the GBA mutation spectrum and for better understanding of the molecular basis of GD.

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center